1-14 of 14
Colin D. Crean
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fingolimod in Combination with Bortezomib Demonstrates Synergistic Tumor Inhibition and Bone Anabolic Effects in Myeloma Bone Disease

Attaya Suvannasankha, Colin D. Crean, David Halladay, David G. Roodman, John Chirgwin
Journal: Blood
Blood (2022) 140 (Supplement 1): 7104–7105.
https://doi.org/10.1182/blood-2022-171069
Published: 2022
Journal Articles

GFI1-Dependent SGPP1 Repression Promotes Growth and Survival of Myeloma Cells

Daniela Nicoleta Petrusca, PhD, Evgeny Berdyshev, PhD, Colin D. Crean, BS, Judith L Anderson, BS, G. David Roodman, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4387.
https://doi.org/10.1182/blood-2019-131106
Published: 2019
Journal Articles

The Gfi1-SphK1 Axis Regulates the Growth and Survival of Myeloma Cells

Daniela Nicoleta Petrusca, PhD, Evgeny Berdyshev, PhD, Patrick Mulcrone, PhD, Colin D. Crean, BS, Judith L Anderson, BS, Quanhong Sun, PhD, Deborah Lynn Galson, PhD, G. David Roodman, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5615.
https://doi.org/10.1182/blood-2018-99-119507
Published: 2018
Journal Articles

Regulation of Osteoblast Function in Myeloma Bone Disease By Semaphorin 4D

Attaya Suvannasankha, MD, Colin D Crean, Douglas R Tompkins, Jesus Delgado-Calle, PhD, Teresita M Bellido, PhD, G. David Roodman, MD PhD, John M Chirgwin, PhD
Journal: Blood
Blood (2016) 128 (22): 4439.
https://doi.org/10.1182/blood.V128.22.4439.4439
Published: 2016
Journal Articles

CD166 Identifies Multiple Myeloma Cells That Preferentially Home to the Bone Marrow Microenvironment and Promote Disease Progression and Bone Lytic Disease

Linlin Xu, Christophe Machal, Hao Wu, Colin D Crean, Bradley Poteat, Angelo A. Cardoso, Helmut Hanenberg, Khalid Mohammad, Attaya Suvannasankha, Edward F Srour
Journal: Blood
Blood (2014) 124 (21): 174.
https://doi.org/10.1182/blood.V124.21.174.174
Published: 2014
Journal Articles

Role Of CD166 In Multiple Myeloma Cell Homing To The Bone Marrow Microenvironment and Disease Progression

Linlin Xu, Christophe Machal, Hao Wu, Bradley Poteat, Colin D. Crean, Angelo A. Cardoso, MD, PhD, John M Chirgwin, PhD, Helmut Hanenberg, MD, Khalid S. Mohammad, M.D. Ph.D., Attaya Suvannasankha, MD, Edward F Srour, PhD
Journal: Blood
Blood (2013) 122 (21): 3102.
https://doi.org/10.1182/blood.V122.21.3102.3102
Published: 2013
Journal Articles

Neonatal Mouse Bone Supports Growth Of Primary Myeloma Cells Ex Vivo and Assessment Of Responses To Antimyeloma Drugs

Attaya Suvannasankha, MD, Douglas R Tompkins, MS, Kateryna Petyaykina, Colin D. Crean, Keith W Condon, PhD, G. David David Roodman, MD, PhD, John M Chirgwin, PhD
Journal: Blood
Blood (2013) 122 (21): 1893.
https://doi.org/10.1182/blood.V122.21.1893.1893
Published: 2013
Journal Articles

A Phase I/II Trial Combining High-Dose Lenalidomide with Melphalan and Autologous Transplant for Multiple Myeloma: A Report of the Phase I Dose-Finding Study.

Attaya Suvannasankha, MD, Sherif Farag, MD, PhD, FRACP, FRCPA, Rebecca Silbermann, M.D., Robin Obryant, RN, Lisa l Wood, RN, Abigail Huljak, Angie Secrest, Colin D. Crean, Rafat Abonour, MD
Journal: Blood
Blood (2012) 120 (21): 3146.
https://doi.org/10.1182/blood.V120.21.3146.3146
Published: 2012
Journal Articles

A Potential Biomarker Panel of Multiple Myeloma Identified Using Label-Free Mass Spectrometry-Based Quantitative Proteomics

Attaya Suvannasankha, MD, Colin D. Crean, Heather M. Sahm, Rafat Abonour, MD, Sherif Farag, MD, PhD, FRACP, FRCPA, Mu Wang, PhD
Journal: Blood
Blood (2011) 118 (21): 2890.
https://doi.org/10.1182/blood.V118.21.2890.2890
Published: 2011
Journal Articles

The Role of the Antiapoptotic Protein c-FLIP in Multiple Myeloma.

Colin D. Crean, Genglin Zhang, Lauren B VanRyckeghem, BS, Helmut Hanenberg, Sherif Farag, MBBS, PhD, Rafat Abonour, Attaya Suvannasankha, MD
Journal: Blood
Blood (2009) 114 (22): 1966.
https://doi.org/10.1182/blood.V114.22.1966.1966
Published: 2009
Journal Articles

The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo , and Shows Synergistic Activity in Combination with Lenalidomide

Xiaojing Wang, PhD, Anthony L. Sinn, Attaya Suvannasankha, MD, Colin D. Crean, Li Chen, MD, Shuhong Zhang, PhD, Jing Liang, MD, Genglin Zhang, Karen E. Pollok, PhD, Rafat Abonour, MD, Carolyn Sidor, MD, Mark R. Bray, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3660.
https://doi.org/10.1182/blood.V112.11.3660.3660
Published: 2008
Journal Articles

Dimethylaminoparthenolide (DMAPT) in Multiple Myeloma

Colin D. Crean, Genglin Zhang, Karen E. Pollok, PhD, Anthony L. Sinn, Peter A Crooks, PhD, Sherif Farag, MBBS, PhD, Rafat Abonour, Attaya Suvannasankha, MD
Journal: Blood
Blood (2008) 112 (11): 3672.
https://doi.org/10.1182/blood.V112.11.3672.3672
Published: 2008
Journal Articles

MOZ and MOZ-CBP Cooperate with NFκB To Induce Expression of NFκB-Dependent Genes.

Edward M. Chan, MD, Rebecca J. Chan, MD-PhD, Elisha M. Comer, JD, Robert J. Goulet, III, MD, Colin D. Crean, Zachary D. Brown, Amy M. Fruehwald, Zhenyun Yang, PhD, Howard S. Boswell, MD, Harikrishna Nakshatri, PhD, Theodore G. Gabig, MD
Journal: Blood
Blood (2007) 110 (11): 887.
https://doi.org/10.1182/blood.V110.11.887.887
Published: 2007
Journal Articles

The Sesquiterpene Lactone Parthenolide Induces Apoptosis and Overcomes the Protective Effect of the Bone Marrow Microenvironment in Human Multiple Myeloma Cells.

Attaya Suvannasankha, MD, Colin D. Crean, Rajasubramaniam Shanmugam, PhD, Rafat Abonour, MD, H. Scott Boswell, MD, Harikrishna Nakshatri, PhD
Journal: Blood
Blood (2006) 108 (11): 5058.
https://doi.org/10.1182/blood.V108.11.5058.5058
Published: 2006